Back to Explorer

Draft Guidance for Industry: Providing Regulatory Submissions in Electronic or Paper Format to the Office of Food Additive Safety

DraftHuman Foods Program03/01/2010
Electronic SignaturesOptical Character Recognition

Description

This guidance, when finalized, will represent the Food and Drug Administration’s (FDA’s) current thinking on this topic. It does not create or confer any rights for or on any person and does not operate to bind FDA or the public. You can use an alternative approach if the approach satisfies the requirements of the applicable statutes and regulations. If you want to discuss an alternative approach, contact the FDA staff responsible for implementing this guidance.  If you cannot identify the appropriate FDA staff, call the telephone number listed on the title page of this guidance.

Key Topics

Terms and concepts identified from this document

Scope & Applicability

Product Classes

2
Food Additive Petition

Type of submission depicted in roadmap examples

New plant variety

Source of the new protein being evaluated.

Stakeholders

2
Division of Dockets Management

Entity receiving written comments on the draft guidance

petitioner

The party submitting a health claim petition to the FDA.

Regulatory Context

Regulatory Activities

10
Food Additive Petition

Formal program for the review of animal food additives.

Pre-Notification Consultation

voluntarily submit a PNC prior to submitting a FCN; Consultation prior to a formal FCN submission.

FCN Submission

Food Contact Notification submission roadmap

FDA ESG

Electronic Submissions Gateway for receiving regulatory information

FDA Electronic Submission Gateway

Transmission of regulatory submissions

Color Additive Petition

Process to obtain approval for unapproved color additives

Food Contact Notification

An FCN should include detailed information on the chemical identity of the FCS.

Generally Recognized as Safe Notice

A GRAS notice submission discussed in Section VI.; Regulatory submission type (GRAS notice); Voluntary procedure to inform FDA of a GRAS determination.; Submission roadmap for GRAS notices; Referenced regulatory submission type.

Biotechnology Final Consultation

A regulatory submission type for biotechnology products discussed in Section VII.; submission regarding Biotechnology Final Consultation; Voluntary procedure for foods derived from new plant varieties; Referenced regulatory submission type.

New Protein Consultation

A regulatory submission type for new proteins discussed in Section VIII.; submission regarding New Protein Consultation; A voluntary procedure for proteins derived from a new plant variety.

Document Types

10
Food Master Files

Documentation artifacts used to support food contact substance notifications.; Submissions containing confidential information for food additives; Documentation containing chemistry or safety information for food substances.

E-submission Documents

Creating Reference Hyperlinks in E-submission Documents

Electronic Submission

Conventions for Naming Files and Folders in an Electronic Submission

Regulatory Submissions

Enhanced (QbD) regulatory submissions documentation.

New Protein Consultation Submission Roadmap

Downloadable foldering structure for electronic submissions.

GRAS Notice Submission Roadmap

Standardized folder structure for electronic GRAS submissions.

FIFRA registration label

Labeling for substances regulated under FIFRA

Comprehensive Toxicology Profile

Contains information on potential carcinogenicity; CTP of all unpublished and published safety studies

FCN Submission Roadmap

foldering structure for electronic FCN submissions; Standardized folder structure for electronic FCN submissions.

Technical bulletins

additional information included in a FCN submission

Attributes

10
electronic format

Required format for all submissions under section 505G(j)

Foldering Structures

Links to Downloadable Foldering Structures

Reference Hyperlinks

Creating Reference Hyperlinks in E-submission Documents

Naming Files and Folders

Conventions for Naming Files and Folders in an Electronic Submission

nondisclosable information

Data designated as confidential by the submitter

Estimated Daily Intake

The amount of an NDI expected to be consumed based on labeling (EDI).; The highest possible total daily intake level of an NDI determined from proposed conditions of use.

Molecular Weight Profile

Percentage of oligomeric species below 1000 Daltons

Daily Intake

Amount of drug product consumed per day used for calculations

Sweetness Potency

Study of the potency of a sweetener

Technical Effect

Characteristic used to distinguish dietary ingredients from food additives.

Technical Details

Substances

6
Food Contact Substances

substances in contact with infant formula and/or human milk

New non-pesticidal protein

Subject of the early food safety evaluation.

3-AP-PEG

Specific impurity (CAS Reg. No. 34901-14-9) mentioned in an amendment example.

Food Additive

Substances intended for use in food that require premarket approval

Color Additive

substance that meets the definition of color additive must be listed

Food Contact Substance

The FCS undergoes chemical or metabolic transformation; Components of the formulation already authorized for intended uses.

Testing Methods

10
Subchronic Toxicity Studies

Safety information in a FAP

Migration study

Analytical procedure to determine the transfer of substances from food contact materials.

Migration testing

Determining expected levels of migration to food

Spectroscopic data

Characterization using IR, NMR, and MassSpec

Metabolism and Pharmacokinetic Studies

safety study subfolder in the FCN roadmap

Carcinogenicity Studies

Section IX of the guidance.

Genetic Toxicity Studies

safety study subfolder in the FCN roadmap; Safety testing including Ames test

Analytical Method

Method used in chemistry submissions for petitions

SubchronicToxicityStudies

Safety studies conducted in rodents and non-rodents

GeneticToxicityStudies

Safety studies such as Ames tests

Processes

6
Manufacturing Method

Changes in method that result in substantive changes in identity

Method of manufacture

Changes in manufacturing suggesting further studies

Manufacturing Process

Changes to this process may affect the identity and NDI status of an ingredient.; Changes to this process may create an NDI; you should describe the manufacturing process and provide detailed information; includes fermentation as an intrinsic part of identity

Manufacturing

Information contained in MFs; Processes described within a Master File.

Batch Certification

Exemption from batch certification for color additives

Toxicological Study

Type of data requiring PDF and spreadsheet formats

Clinical Concepts

4
Carcinogenicity

Assessing the carcinogenicity risk of immunomodulators

Dietary exposure

Safety assessment element in GRAS notices

Neurotoxicity

Grade ≥ 3 neurotoxicity

Reproductive Toxicity

Safety study type for reproduction

Standards & References

External Standards

4
Standard for Exchange of Non-Clinical Data

Referenced safety study information standard.

XML

Extensible markup language file format

SDTM

The Study Data Tabulation Model (SDTM) and Analysis Data Model (ADaM) specifications provided in this document

SEND

Standard for Exchange of Nonclinical Data; Standard for Exchange of Nonclinical Data for toxicology studies.; Standard for Exchange of Nonclinical Data provides structure for nonclinical tabulation datasets; Standard for nonclinical data tabulation; Standard for nonclinical study data; Standard for nonclinical tabulation data; dataset submitted to the FDA for nonclinical trials

Specifications

5
proposed tolerance

Required in petitions if necessary to ensure safety; Proposed text for the tolerance provision to ensure safety

Specifications for food-grade material

Quality criteria for substances in GRAS notices

RawMaterialSpecs

Specifications for reagents, solvents, and catalysts

Raw material specifications

data not identified on Form FDA 3480

Specifications

Specifications to identify dietary ingredients, other ingredients, and contaminants

Related CFR Sections (15)

Enforcement Impact

Deficiencies cited in Warning Letters referencing the same regulations

Adulterated under section 402(a)(2)(C)(i)
22
Unfair or deceptive acts or practices
6
Unfair or Deceptive Marketing
5
Unapproved new drugs
4
Misbranded drugs
3
Prohibited act under section 301(ll)
3
Adulterated human foods
3
Introduction of adulterated food into interstate commerce
3
unapproved new drugs
2
Adulterated food containing an unsafe food additive
2

Related Warning Letters (10)

Related MFDS Guidelines

Korean regulatory guidelines covering similar topics

See Also (8)